Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry

This is the authors' abstract. We don't add key points for this paper.

The US Food and Drug Administration says that it takes conflicts of interest seriously. But financial entanglements with the drug industry are common among its leaders. Peter Doshi reports